Actuate Therapeutics (ACTU) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.61, +21.00% vs the prior close of $0.50.
- Volume 884.74K shares, 2.4x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ACTU jumps 21.0% to $0.61 on 2.4x normal volume. Closed at $0.61, +21.00% vs the prior close of $0.50. Day range $0.47–$0.64, opened at $0.49.
ACTU daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ACTU jumps 21.0% to $0.61 on 2.4x normal volume
- Closed at $0.61, +21.00% vs the prior close of $0.50. Day range $0.47–$0.64, opened at $0.49.
- Volume was 884.74K shares, 2.4x its 50-day average of 374.60K — unusually heavy trading.
- Price is -40.3% vs its 50-day average ($1.01) and -75.2% vs its 200-day average ($2.44).
- 52-week range $0.41–$8.20; today's close sits at 3% of that range, 92.6% below the 52-week high.
Oct 15, 2026 — ACTU jumps 15.2% to $0.50
- Closed at $0.50, +15.21% vs the prior close of $0.43. Day range $0.43–$0.55, opened at $0.46.
- Volume was 472.10K shares, 1.3x its 50-day average of 368.69K.
- Price is -51.3% vs its 50-day average ($1.03) and -79.7% vs its 200-day average ($2.46).
- 52-week range $0.41–$8.20; today's close sits at 1% of that range, 93.9% below the 52-week high.
Oct 14, 2026 — ACTU slides 6.9% to $0.43, a 52-week low
- Closed at $0.43, -6.87% vs the prior close of $0.47. Day range $0.41–$0.49, opened at $0.48.
- Volume was 439.40K shares, 1.2x its 50-day average of 366.10K.
- Price is -58.2% vs its 50-day average ($1.04) and -82.6% vs its 200-day average ($2.49).
- 52-week range $0.41–$8.27; today's close sits at 0% of that range, 94.7% below the 52-week high.
Oct 13, 2026 — ACTU slides 27.6% to $0.47, a 52-week low on 2.8x normal volume
- Closed at $0.47, -27.64% vs the prior close of $0.64. Day range $0.44–$0.66, opened at $0.66.
- Volume was 967.70K shares, 2.8x its 50-day average of 350.24K — unusually heavy trading.
- Price is -55.7% vs its 50-day average ($1.05) and -81.5% vs its 200-day average ($2.52).
- 52-week range $0.44–$8.30; today's close sits at 0% of that range, 94.4% below the 52-week high.
Oct 12, 2026 — ACTU jumps 5.6% to $0.64
- Closed at $0.64, +5.57% vs the prior close of $0.61. Day range $0.60–$0.68, opened at $0.60.
- Volume was 285.90K shares, 0.8x its 50-day average of 347.67K.
- Price is -39.5% vs its 50-day average ($1.06) and -74.8% vs its 200-day average ($2.55).
- 52-week range $0.60–$8.49; today's close sits at 1% of that range, 92.4% below the 52-week high.
Oct 9, 2026 — ACTU slides 10.2% to $0.61, a 52-week low, 4 down days in a row
- Closed at $0.61, -10.16% vs the prior close of $0.68. Day range $0.61–$0.68, opened at $0.64.
- Volume was 295.00K shares, 0.8x its 50-day average of 347.12K.
- Price is -43.2% vs its 50-day average ($1.07) and -76.4% vs its 200-day average ($2.58).
- 52-week range $0.60–$8.49; today's close sits at 0% of that range, 92.8% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — ACTU slides 6.2% to $0.68, 3 down days in a row
- Closed at $0.68, -6.22% vs the prior close of $0.72. Day range $0.62–$0.72, opened at $0.68.
- Volume was 324.50K shares, 0.9x its 50-day average of 341.82K.
- Price is -37.4% vs its 50-day average ($1.08) and -74.0% vs its 200-day average ($2.61).
- 52-week range $0.60–$8.49; today's close sits at 1% of that range, 92.0% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — ACTU slides 10.8% to $0.72 on 1.9x normal volume
- Closed at $0.72, -10.84% vs the prior close of $0.81. Day range $0.62–$0.72, opened at $0.64.
- Volume was 637.90K shares, 1.9x its 50-day average of 333.35K — unusually heavy trading.
- Price is -33.7% vs its 50-day average ($1.09) and -72.6% vs its 200-day average ($2.64).
- 52-week range $0.60–$8.49; today's close sits at 2% of that range, 91.5% below the 52-week high.
Oct 6, 2026 — ACTU slides 7.2% to $0.81
- Closed at $0.81, -7.20% vs the prior close of $0.88. Day range $0.76–$0.89, opened at $0.89.
- Volume was 337.70K shares, 1.0x its 50-day average of 331.12K.
- Price is -26.1% vs its 50-day average ($1.10) and -69.6% vs its 200-day average ($2.68).
- 52-week range $0.60–$8.49; today's close sits at 3% of that range, 90.4% below the 52-week high.
- SEC filings that day: S-1.
Oct 5, 2026 — ACTU jumps 6.8% to $0.88
- Closed at $0.88, +6.84% vs the prior close of $0.82. Day range $0.80–$0.93, opened at $0.85.
- Volume was 201.90K shares, 0.6x its 50-day average of 328.95K.
- Price is -20.9% vs its 50-day average ($1.11) and -67.7% vs its 200-day average ($2.71).
- 52-week range $0.60–$8.49; today's close sits at 3% of that range, 89.7% below the 52-week high.
Oct 2, 2026 — ACTU slides 7.9% to $0.82
- Closed at $0.82, -7.87% vs the prior close of $0.89. Day range $0.80–$0.95, opened at $0.93.
- Volume was 91.90K shares, 0.3x its 50-day average of 329.48K — lighter than usual.
- Price is -26.4% vs its 50-day average ($1.11) and -70.1% vs its 200-day average ($2.74).
- 52-week range $0.60–$8.49; today's close sits at 3% of that range, 90.4% below the 52-week high.
ACTU latest news & SEC filings
Every SEC filing by or about ACTU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form S-1/A — S-1/A filing
S-1/A filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 8, 2026 · Form FWP — Free writing prospectus (offering marketing material)
Free writing prospectus (offering marketing material)
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 6, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$4.87M (prior year -$5.95M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.20 (prior year -$0.30) (loss narrowed vs Jun 30, 2025)
Jul 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Things to know before you trade ACTU
- How much it moves: over the last 20 sessions the average daily move was 11.05% (largest 27.6%). That is a volatile stock.
- Liquidity: about 378.47K shares (≈$228.97K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.61 vs a range of $0.41–$8.20 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 8 sales; latest: Todd S Thomson sold 280,000 shares on Jan 5, 2026.
- Latest filings: 10-Q Aug 14, 2026; 8-K Jul 17, 2026; 8-K May 22, 2026.
- Share count: 24.01M shares outstanding (Aug 13, 2026), +15.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ACTU market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.49 | 0.64 | 0.47 | 0.61 | 884.74K |
| Oct 15, 2026 | 0.46 | 0.55 | 0.43 | 0.50 | 472.10K |
| Oct 14, 2026 | 0.48 | 0.49 | 0.41 | 0.43 | 439.40K |
| Oct 13, 2026 | 0.66 | 0.66 | 0.44 | 0.47 | 967.70K |
| Oct 12, 2026 | 0.60 | 0.68 | 0.60 | 0.64 | 285.90K |
| Oct 9, 2026 | 0.64 | 0.68 | 0.61 | 0.61 | 295.00K |
| Oct 8, 2026 | 0.68 | 0.72 | 0.62 | 0.68 | 324.50K |
| Oct 7, 2026 | 0.64 | 0.72 | 0.62 | 0.72 | 637.90K |
| Oct 6, 2026 | 0.89 | 0.89 | 0.76 | 0.81 | 337.70K |
| Oct 5, 2026 | 0.85 | 0.93 | 0.80 | 0.88 | 201.90K |
| Oct 2, 2026 | 0.93 | 0.95 | 0.80 | 0.82 | 91.90K |
| Oct 1, 2026 | 0.80 | 0.96 | 0.76 | 0.89 | 494.10K |
| Sep 30, 2026 | 0.71 | 0.83 | 0.69 | 0.78 | 409.60K |
| Sep 29, 2026 | 0.74 | 0.75 | 0.68 | 0.69 | 111.00K |
| Sep 28, 2026 | 0.69 | 0.74 | 0.60 | 0.74 | 276.90K |
| Sep 25, 2026 | 0.65 | 0.75 | 0.64 | 0.68 | 382.80K |
| Sep 24, 2026 | 0.75 | 0.75 | 0.61 | 0.62 | 272.50K |
| Sep 23, 2026 | 0.80 | 0.87 | 0.72 | 0.73 | 222.00K |
| Sep 22, 2026 | 0.90 | 0.93 | 0.80 | 0.81 | 187.20K |
| Sep 21, 2026 | 0.99 | 1.02 | 0.89 | 0.91 | 274.50K |
About Actuate Therapeutics
Actuate Therapeutics (ACTU) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in FORT WORTH, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1652935.
ACTU board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Aaron G.L. Fletcher | Director | May 22, 2026 |
| Martin H. Jr. Huber | Director | May 22, 2026 |
| Venture Partners Ii, L.P. Kairos | Director | Jan 7, 2026 |
| Jason A Keyes | Director | May 22, 2026 |
| Amy L Ronneberg | Director | May 22, 2026 |
| Daniel M Schmitt | President, CEO and Director | Aug 14, 2026 |
| Roger Sawhney | Director | May 22, 2026 |
| Todd S Thomson | Director | May 22, 2026 |
| Dan Zabrowski | Director | May 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paul J Lytle | Chief Financial Officer | Apr 1, 2026 |
| Andrew Paul Mazar | Chief Operating Officer | Apr 1, 2026 |
| Daniel M Schmitt | President, CEO and Director | Aug 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jan 5, 2026 | Todd S Thomson | Sale | 280,000 | $5.80 |
| Jan 5, 2026 | Todd S Thomson | Sale | 280,000 | $5.80 |
| Jan 5, 2026 | Venture Partners Ii, L.P. Kairos | Sale | 280,000 | $5.80 |
| Jan 5, 2026 | Venture Partners Ii, L.P. Kairos | Sale | 280,000 | $5.80 |
| Jan 5, 2026 | Todd S Thomson | Sale | 280,000 | $5.80 |
| Jan 5, 2026 | Todd S Thomson | Sale | 280,000 | $5.80 |
| Jan 5, 2026 | Venture Partners Ii, L.P. Kairos | Sale | 280,000 | $5.80 |
| Jan 5, 2026 | Venture Partners Ii, L.P. Kairos | Sale | 280,000 | $5.80 |
ACTU financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-22.23M | -1.06 | $-19.21M |
| Dec 31, 2024 | — | $-27.29M | -3.26 | $-21.84M |
| Dec 31, 2023 | — | $-24.74M | -17.24 | $-21.63M |
Latest balance sheet: total assets $5.20M, total liabilities $4.21M, cash $4.43M (as of Jun 30, 2026).
ACTU earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ACTU
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.